Search

Your search keyword '"Dhande, Sonal"' showing total 8 results
Start Over Author "Dhande, Sonal"
8 results on '"Dhande, Sonal"'

1. The Efficacy of Paxman Scalp Cooling System in Preventing Hair Loss in Breast Cancer Patients Receiving Chemotherapy in Western India – Multi-centre Retrospective Cohort Study

Author

Mekha, Mangesh, primary, Joshi, Ashish, additional, Maniar, Vashishth, additional, Maheshwari, Udip, additional, Joshi, Kshitij, additional, Kalaskar, Pritam, additional, Sheth, Smit, additional, Kendre, Pradip, additional, Morzaria, Disha, additional, Korgavkar, Reshma, additional, Pethe, Chandrashekhar, additional, and Dhande, Sonal, additional

Published
2024
Full Text
View/download PDF

5. Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial

Author

Nagarkar, Rajnish, primary, Patil, Darshana, additional, Crook, Timothy, additional, Datta, Vineet, additional, Bhalerao, Sagar, additional, Dhande, Sonal, additional, Palwe, Vijay, additional, Roy, Shirsendu, additional, Pandit, Prakash, additional, Ghaisas, Ashwini, additional, Page, Raymond, additional, Kathuria, Harjeetsingh, additional, Srinivasan, Ajay, additional, and Akolkar, Dadasaheb, additional

Published
2019
Full Text
View/download PDF

7. Encyclopedic Tumor Analysis for Treatment of Advanced, Broadly Refractory Cancers: Interim Results from the RESILIENT Trial

Author

Patil, Darshana, primary, Nagarkar, Raj, additional, Crook, Tim, additional, Datta, Vineet, additional, Ranade, Anantbhushan, additional, Bhatt, Amit, additional, Bhalerao, Sagar, additional, Dhande, Sonal, additional, Palwe, Vijay, additional, Roy, Shirsendu, additional, Pandit, Prakash, additional, Page, Raymond, additional, Srinivasan, Ajay, additional, Devhare, Pradip, additional, Fulmali, Pradip, additional, Apurwa, Sachin, additional, Patil, Sanket, additional, Pawar, Sushant, additional, and Akolkar, Dadasaheb, additional

Published
2018
Full Text
View/download PDF

8. Does Her2Neu Overexpression Influence Prognosis Of Hormone Receptor Positive Breast Cancers ?

Author

Bapsy, P. P., Shivkumar, Swarna, and Dhande, Sonal Chandrakant

Subjects
HORMONE receptor positive breast cancer, TRIPLE-negative breast cancer
Abstract

Introduction The heterogeneous nature of breast cancer is depicted with genotypic and phenotypic diversity. Her2neu positivity is seen in 15-20% of the breast cancers and is associated with increased tumour aggressiveness with decreased DFS and OS. Molecular subclassification of breast cancer is increasingly emphasized in the personalized care of breast cancer. We evaluated the role of Her2neu expression or amplification in prognosticating breast cancer. Methods and materials We retrospectively evaluated 192 breast cancer patients at our institute from 1st January 2008 to 31st The patients were subcategorized into four groups, namely: hormone receptor positive group(ER+PR+ Her2neu0), Triple positive group, triple negative group and the ER0PR0 Her2neu+ group. The prevalence of high Ki67, grade 3 tumours and lymph node positivity was noted across all the groups. The 5 yr OS and 5 yr PFS was calculated in each group. Results The prevalence of high Ki67 and grade 3 tumours was highest in the triple negative breast cancer group (87.5%, 83.3%) followed by ER0PR0 Her2neu+ group (84.4%, 78.1%), triple positive group (72.7%, 63.6%) and in the ER+PR+Her2neu0 group (38.2%, 35.3%). The 5 yr OS was highest (92%) in the ER+PR+ Her2neu0 group followed by ER0PR0 Her2neu + group(72%), triple positive group (68%) and least was in the triple negative group (39%). The 5 yr PFS was 86% in the ER+PR+ Her2neu0 group, followed by 61% in the ER0PR0 Her2neu+ disease, 56% in the triple positive group and 24% in the triple negative breast cancer. The 5 yr OS and 5 yr PFS was statistically significant (p [ABSTRACT FROM AUTHOR]

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results